CIGARETTE SMOKE INCREASES THE RISK OF INFECTIONS

Reading time is 2 mins

.
.
HOW DOES CIGARETTE SMOKE INCREASE INFECTION RISK?

Turkey Medicals hospital member and Turkish thorax Association Tobacco Working Group, which made a statement due to World smoking cessation day, noted that cigarette smoke increases the risk of infection with the virus.

Covid-19 infection has caused 2.5 million deaths worldwide since the beginning of the pandemic. Tobacco use causes 8 million deaths worldwide every year.

At the beginning of the Pandemic, there were false reports that the tobacco industry was involved, that smokers had a lower risk of covid-19 infections. But many subsequent studies showed that the risk of severe disease and death due to the Covid-19 virus was at least 2.5 times higher in patients using tobacco. The Turkish thorax Association Tobacco Working Group noted this risk, noting that smokers are also more likely to infect the virus through smoke, and made statements on February 9, world Smoking Cessation day.

.
INCREASED RISK OF INFECTION BY CIGARETTE SMOKE

A statement noting the risk posed by smoking, hookah smoke included the following words:

“The World Health Organization also states that smokers can catch the Covid-19 virus more quickly because they often take their hands to their lips, and they can also pass the disease more seriously due to decreased lung capacity. In addition, smokers also increase the risk of infecting others with cigarette smoke if they carry the virus. The World Health Organization reports that tobacco products shared in common areas, such as hookahs, also increase transmission of the virus. As is known, tobacco use significantly increases the risk of respiratory diseases such as COPD and lung cancer, as well as cardiovascular diseases. Covid-19 infection also causes direct damage primarily to the lungs and cardiovascular system. Therefore, these diseases that develop due to the use of tobacco products are a direct risk factor for severe Covid-19 infection.”
“Smokers have covid-19 heavier ” smokers have Covid-19 heavier”

.
HIGHER RISK OF DEATH IN SMOKERS

Noting that tobacco product use also weakens the immune response by different mechanisms, leading to an increased risk of respiratory infections, the Working Group concluded its statement as follows::

“For Covid-19, smoking has been identified as a clear risk factor for severe disease, attachment to a respirator, and death. Covid-19 infection causes months of permanent damage to the lungs of some patients, negatively affects respiratory function and significantly reduces their effort capacity. Smoking also has a healing retardant effect. Therefore, people who have Covid-19 infection should never smoke. People who smoke should turn the pandemic into an opportunity to quit smoking.

On the other hand, as the world struggles with the pandemic, the tobacco industry has tried to refresh its image and make it look public health friendly by donating personal protective equipment, respirators. In return, many countries have asked their governments to relax Tobacco Control and have tried to obtain licenses for newly heated tobacco products.

On February 9 2021, the Smoking Cessation day, the Turkish thorax Association Tobacco Working Group recommends that all tobacco users not come to the tobacco industry’s games and stop using tobacco, knowing that the pandemic is an opportunity.”

.
.
.

Follow me
President of Organ Transplant Center at MedicalPark Hospital Antalya

Turkey's world-renowned organ transplant specialist. Dr. Demirbaş has 104 international publications and 102 national publications.

Physician's Resume:

Born on August 7, 1963 in Çorum, Prof. Dr. Alper Demirbaş has been continuing his work as the President of MedicalPark Antalya Hospital Organ Transplantation Center since 2008.

Prof. who performed the first tissue incompatible kidney transplant in Turkey, the first blood type incompatible kidney transplant, the first kidney-pancreas transplant program and the first cadaveric donor and live donor liver transplant in Antalya. Dr. As of August 2016, Alper Demirbaş has performed 4900 kidney transplants, 500 liver transplants and 95 pancreas transplants.

In addition to being the chairman of 6 national congresses, he has also been an invited speaker at 12 international and 65 national scientific congresses. Dr. Alper Demirbaş was married and the father of 1 girl and 1 boy.

Awards:

Eczacibasi Medical Award of 2002, Akdeniz University Service Award of 2005, Izder Medical Man of the Year Award of 2006, BÖHAK Medical Man of the Year Award of 2007, Sabah Mediterranean Newspaper Scientist of the Year Award of 2007, ANTIKAD Scientist of the Year Award of 2009, Social Ethics Association Award of 2010, Işık University Medical Man of the Year Award of 2015, VTV Antalya's Brand Value Award of 2015.

Certificates:

Doctor of Medicine Degree Hacettepe University Faculty of Medicine Ankara, General Surgeon Ministry of Health Turkey EKFMG (0-477-343-8), University of Miami School of Medicine Member of Multiple Organ Transplant, ASTS Multiorgan Transplant Scholarship. Lecturer at Kyoto University. Lecturer at University of Essen, Research assistant at the University of Cambridge .

Professional Members:

American Society of Transplant Surgeons, American Transplantation Society Nominated, Middle East and Southern Africa Council Transplantation Society 2007, International Liver Transplantation Association, Turkish Transplantation Association, Turkish Society of Surgery, Turkish Hepatobiliary Surgery Association.

Disclaimer:

Our website contents consist of articles approved by our Web and Medical Editorial Board with the contributions of our physicians. Our contents are prepared only for informational purposes for public benefit. Be sure to consult your doctor for diagnosis and treatment.
Medically Reviewed by Professor Doctor Alper Demirbaş
Follow me